HomeFULC • NASDAQ
add
Fulcrum Therapeutics Inc
Previous close
$8.37
Day range
$7.82 - $8.37
Year range
$2.32 - $10.09
Market cap
428.08M USD
Avg Volume
604.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.56M | -10.23% |
Net income | -19.60M | 9.68% |
Net profit margin | — | — |
Earnings per share | -0.31 | 33.09% |
EBITDA | -21.51M | 5.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 200.64M | -22.00% |
Total assets | 214.86M | -22.99% |
Total liabilities | 16.49M | -24.06% |
Total equity | 198.37M | — |
Shares outstanding | 54.12M | — |
Price to book | 2.28 | — |
Return on assets | -24.63% | — |
Return on capital | -25.58% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -19.60M | 9.68% |
Cash from operations | -14.19M | 25.60% |
Cash from investing | 18.61M | 327.86% |
Cash from financing | 64.00K | -89.92% |
Net change in cash | 4.49M | 131.84% |
Free cash flow | -7.41M | 39.45% |
About
Founded
2015
Website
Employees
45
